Clostridium difficile Infection is Associated with Graft Loss in Solid Organ Transplant Recipients.

Béguelin, Charles Antoine; Cusini, Alexia; Stampf, S; Boggian, K; Garzoni, C; Koller, M; Manuel, O; Meylan, P; Mueller, N J; Hirsch, H; Weisser, M; Berger, C; van Delden, C (2018). Clostridium difficile Infection is Associated with Graft Loss in Solid Organ Transplant Recipients. American journal of transplantation, 18(7), pp. 1745-1754. Wiley-Blackwell 10.1111/ajt.14640

Cusini_et_al-2018-American_Journal_of_Transplantation.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (429kB) | Preview
[img] Text
Cusini_et_al-2018-American_Journal_of_Transplantation.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (366kB) | Request a copy

Clostridium difficile infection (CDI) is a leading cause of infectious diarrhea in solid organ transplant recipients (SOT). We aimed to assess incidence, risk factors and outcome of CDI within the Swiss Transplant Cohort Study (STCS). We performed a case-control study of SOT recipients in the STCS diagnosed with CDI between May 2008 and August 2013. We matched two control subjects per case by age at transplantation, sex and transplanted organ. A multivariable analysis was performed using conditional logistic regression to identify risk factors and evaluate outcome of CDI. Two thousand one hundred and fifty-eight SOT recipients, comprising 87 cases of CDI and 174 matched controls were included. The overall CDI rate per 10'000 patient days was 0.47 (95% confidence interval (CI): [0.38, 0.58]), with the highest rate in lung (1.48, 95% CI: [0.93, 2.24]). In multivariable analysis, proven infections (hazard ratio (HR) 2.82, 95% CI: [1.29, 6.19]) and antibiotic treatments (HR=4.51, 95% CI: [2.03, 10.0]) during the preceding three months were independently associated with the development of CDI. Despite mild clinical presentations, recipients acquiring CDI post-transplantation had an increased risk of graft loss (HR=2.24, 95% CI: [1.15, 4.37], p=0.02). These findings may help to improve the management of SOT recipients. This article is protected by copyright. All rights reserved.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Béguelin, Charles Antoine, Cusini, Alexia


600 Technology > 610 Medicine & health








Annelies Luginbühl

Date Deposited:

10 Apr 2018 11:33

Last Modified:

05 Dec 2022 15:09

Publisher DOI:


PubMed ID:





Actions (login required)

Edit item Edit item
Provide Feedback